Prognosis of gastrointestinal smooth-muscle (stromal) tumors: Dependence on anatomic site

American Journal of Surgical Pathology

Volumn 23, Issue 1, 1999, Pages 82-87

  Emory, Theresa S ^a   Sobin, Leslie H ^a   Lukes, Laura ^a   Lee, Dong H ^a   O'Leary, Timothy J ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

Bowel; Colon; Duodennm; Esophagus; GIST; Ileum; Jejunum; Leiomyoma; Leiomyosarcoma; Mesentery; Omentum; Rectum; Stomach

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; COLORECTAL TUMOR; ESOPHAGUS TUMOR; GASTROINTESTINAL TUMOR; HUMAN; MAJOR CLINICAL STUDY; MESENTERY TUMOR; MITOSIS INDEX; PERITONEUM TUMOR; PROGNOSIS; SCHOOL CHILD; SMALL INTESTINE TUMOR; STOMACH TUMOR; TUMOR LOCALIZATION; TUMOR VOLUME;

ADOLESCENT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MITOTIC INDEX; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SMOOTH MUSCLE TUMOR; STROMAL CELLS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 0032955439     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199901000-00009     Document Type: Article

References (48)

1. Appelman HD. Smooth muscle tumors of the gastrointestinal tract. What we know now that Stout didn't know. Am J Surg Pathol 1986;10(suppl 1):83-99.
2. Appelman HD, Helwig EB. Sarcomas of the stomach. Am J Clin Pathol 1977;67:2-10.
3. Appelman HD, Helwig EB. Gastric epithelioid leiomyoma and leiomyosarcoma (leiomyoblastoma). Cancer 1976;38:708-28.
4. Brainard JA, Goldblum JR. Stromal tumors of the jejunum and ileum: a clinicopathologic study of 39 cases. Am J Surg Pathol 1997;21:407-16.
5. Burke HB, Goodman PH, Rosen DB, et al. Artificial neural networks improve the accuracy of cancer survival prediction. Cancer 1997;79:857-62.
6. Cai J, Jiang Y, Zhang Y, Lu G, Zhang X, Gao Q, Zuo L. Quantitation of P53 protein expression in gastrointestinal smooth muscle tumors. Clinicopathological correlation and prognostic significance. Clin Med J (Engl) 1995;108:669-73.
7. Carrillo R, Candia A, Rodriguez-Peralto JL, Caz V. Prognostic significance of DNA ploidy and proliferative index (MIB-1 index) in gastrointestinal stromal tumors. Hum Pathol 1997;28:160-5.
8. Chou FF, Eng HL, Sheen-Chen SM. Smooth muscle tumors of the gastrointestinal tract: analysis of prognostic factors. Surgery 1996; 119:171-7.
9. Cooper PN, Quirke P, Hardy GJ, Dixon MF. A flow cytometric, clinical, and histological study of stromal neoplasms of the gastrointestinal tract. Am J Surg Pathol 1992;16:163-70.
10. Cox DR. Regression models and life tables. J Royal Statist Soc 1972;34:187-220.
11. Cunningham RE, Federspiel BH, McCarthy WF, Sobin LH, O'Leary TJ. Predicting prognosis of gastrointestinal smooth muscle tumors. Role of clinical and histologic evaluation, flow cytometry, and image cytometry. Am J Surg Pathol 1993;17:588-94.
12. el-Naggar AK, Ro JY, McLemore D, Garnsey L, Ordonez N, Mackay B. Gastrointestinal stromal tumors: DNA flow-cytometric study of 58 patients with at least five years of follow-up. Mod Pathol 1989;2:511-5.
13. el-Rifai W, Sarlomo-Rikala M, Miettinen M, Knuutila S, Andersson LC. DNA copy number losses in chromosome 14: an early change in gastrointestinal stromal tumors. Cancer Res 1996;56: 3230-3.
14. Emory TS, Derringer GA, Sobin LH, O'Leary TJ. Ki-67 (MIB-1) immunohistochemistry as a prognostic factor in gastrointestinal smooth-muscle tumors. J Surg Pathol 1997;2:239-42.
15. Evans HL. Smooth muscle tumors of the gastrointestinal tract. A study of 56 cases followed for a minimum of 10 years. Cancer 1985;56:2242-50.
16. Federspiel BH, Sobin LH, Helwig EB, Mikel UV, Bahr GF. Morphometry and cytophotometric assessment of DNA in smooth-muscle tumors (leiomyomas and leiomyosarcomas) of the gastro-intestinal tract. Anal Quant Cytol Histol 1987;9:105-14.
17. Flint A, Appelman HD, Beckwith AL. DNA analysis of gastric stromal neoplasms; correlation with pathologic features. Surg Pathol 1989;2:117-24.
18. Franquemont DW. Differentiation and risk assessment of gastro-intestinal stromal tumors. Am J Clin Pathol 1995;103:41-7.
19. Franquemont DW, Frierson HF Jr. Proliferating cell nuclear antigen immunoreactivity and prognosis of gastrointestinal stromal tumors. Mod Pathol 1995;8:473-7.
20. Franquemont DW, Geary WA. Gastrointestinal stromal tumors and proliferating cell nuclear antigen. Prognostic challenges [Editorial]. Am J Clin Pathol 1993;100:369-70.
21. Ghnassia JP, Wagner M, Velten M. [Stromal tumors of the digestive tract. Prognostic evaluation of a series of 36 cases]. Ann Pathol 1996;16:27-32.
22. Goldblum JR, Appelman HD. Stromal tumors of the duodenum. A histologic and immunohistochemical study of 20 cases. Am J Surg Pathol 1995;19:71-80.
23. Haque S, Dean PJ. Stromal neoplasms of the rectum and anal canal. Hum Pathol 1992;23:762-7.
24. Kiyabu MT, Bishop PC, Parker JW, Turner RR, Fitzgibbons PL. Smooth muscle tumors of the gastrointestinal tract. Flow cytometric quantitation of DNA and nuclear antigen content and correlation with histologic grade. Am J Surg Pathol 1988;12:954-60.
25. Koga H, Ochiai A, Nakanishi Y, et al. Reevaluation of prognostic factors in gastric leiomyosarcoma. Am J Gastroenterol 1995;90: 1307-12.
26. Lavin P, Hajdu SI, Foote FW. Gastric and extragastric leiomyoblastomas. Clinicopathologic study of 44 cases. Cancer 1972;29: 305-11.
27. Lee JS, Nascimento AG, Farnell MB, Carney JA, Harmsen WS, Ilstrup DM. Epithelioid gastric stromal tumors (leiomyoblastomas): a study of fifty-five cases. Surgery 1995;118:653-60; discussion 660-1.
28. Lee YT. Leiomyosarcoma of the gastro-intestinal tract: general pattern of metastasis and recurrence. Cancer Treat Rev 1983;10: 91-101.
29. Lerma E, Lee SJ, Tugues D, Oliva E, Gich I, Prat J. Ploidy of 36 stromal tumors of the gastrointestinal tract. A comparative study with flow cytometry and image analysis. Anal Quant Cytol Histol 1994;16:435-40.
30. Lerma E, Oliva E, Tugues D, Prat J. Stromal tumours of the gastrointestinal tract: a clinicopathological and ploidy analysis of 33 cases. Virchows Arch 1994;424:19-24.
31. Lewin KJ, Riddell RH, Weinstein WM. Mesenchymal Tumors. Gastrointestinal Pathology and Its Clinical Implications. New York: Igaku-Shoin Medical Publishers; 1992;284-339.
32. Ng E, Pollock RE, Rohmsdahl NM. Prognostic implication of patterns of failure for gastrointestinal leiomyosarcomas. Cancer 1992;69:1334-41.
33. Oyama T, Watanabe H, Iwafuchi M, Maejima T, Ajioka Y. Diagnostic value of proliferating cell nuclear antigen for myogenic tumors of the stomach. Gastroenterol Jpn 1993;28:193-200.
34. Pike AM, Lloyd RV, Appelman HD. Cell markers in gastrointestinal stromal tumors. Hum Pathol 1988;19:830-4.
35. Ranchod M, Kempson RL. Smooth muscle tumors of the gastrointestinal tract and retroperitoneum: a pathologic analysis of 100 cases. Cancer 1977;39:255-62.
36. Ray R, Tahan SR, Andrews C, Goldman H. Stromal tumors of the stomach: prognostic value of the PCNA index. Mod Pathol 1994; 7:26-30.
37. Ricci A Jr, Ciccarelli O, Cartun RW, Newcomb P. A clinicopathlogic and immunohistochemical study of 16 patients with small intestinal leiomyosarcoma. Limited utility of immunophenotyping. Cancer 1987;60:1790-9.
38. Rich-Edwards JW, Corsano KA, Stampfer MJ. Test of the National Death Index and Equifax Nationwide Death Search. Am J Epidemiol 1994;140:1016-9.
39. Roy M, Sommers SC. Metastatic potential of gastric leiomyosarcoma. Pathol Res Pract 1989;185:874-7.
40. Sbaschnig RJ, Cunnningham RE, Sobin LH, O'Leary TJ. Proliferating-cell nuclear antigen immunocytochemistry in the evaluation of gastrointestinal smooth-muscle tumors. Mod Pathol 1994;7: 780-3.
41. Shimamoto T, Haruma K, Sumii K, Kajiyama G, Tahara E. Flow cytometric DNA analysis of gastric smooth muscle tumors. Cancer 1992;70:2031-4.
42. Shimamoto T, Haruma K, Tanaka S, Todo H, Yoshihara M, Sumii K, Kajiyama G. Usefulness of nucleolar organizer region staining in gastric myogenic tumors: correlation with ploidy by DNA flow cytometry. Oncology 1993;50:52-6.
43. Shiu MH, Farr GH, Papachristou DN, Hajdu SI. Myosarcomas of the stomach. Natural history, prognostic factors and management. Cancer 1982;49:177-87.
44. Suzuki H, Sugihira N. Prognostic value of DNA ploidy in primary gastric leiomyosarcoma. Br J Surg 1993;80:1549-50.
45. Tsushima K, Rainwater LM, Goellner JR, van Heerden JA, Lieber MM. Leiomyosarcomas and benign smooth muscle tumors of the stomach: Nuclear DNA patterns studied by flow cytometry. Mayo Clin Proc 1987;62:275-80.
46. Tworek JA, Appelman HD, Singleton TP, Greenson JK. Stromal tumors of the jejunum and ileum. Mod Pathol 1997;10:200-9.
47. Vrettou E, Karkavelas G, Christoforidou B, Meditskou S, Papadimitriou CS. Immunohistochemical phenotyping and PCNA detection in gastrointestinal stromal tumors. Anticancer Res. 1995; 15:943-9.
48. Wijsman JH, Van Dierendonck JH, Keijzer R, van de Velde CJ, Cornelisse CJ. Immmunoreactivity of proliferating cell nuclear antigen compared with bromodeoxyuridine incorporation in normal and neoplastic rat tisssue [see comments]. J Pathol 1992;168:75-83.